Neuroprotection by nitrous oxide and xenon and its relation to minimum alveolar concentration.
Abraini
Jacques H
JH
David
Hélène N
HN
Nicole
Olivier
O
MacKenzie
Eric T
ET
Buisson
Alain
A
Lemaire
Marc
M
D018685:Anesthetics, Inhalation / Q000493:pharmacokinetics / Q000494:pharmacology*; D000818:Animals; D020244:Infarction, Middle Cerebral Artery / Q000517:prevention & control; D051379:Mice; D018696:Neuroprotective Agents; D009609:Nitrous Oxide / Q000493:pharmacokinetics / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000378:metabolism*; D016194:Receptors, N-Methyl-D-Aspartate / Q000187:drug effects; D020521:Stroke / Q000188:drug therapy; D014978:Xenon / Q000493:pharmacokinetics / Q000494:pharmacology*
D018685:Anesthetics, Inhalation; D018696:Neuroprotective Agents; D016194:Receptors, N-Methyl-D-Aspartate; D014978:Xenon; D009609:Nitrous Oxide